Neurofinity

FOUNDERS MESSAGE

Our founders, intimately experienced the effects of the opioid epidemic. That was the catalyst for this effort.

We brought together world-renowned neuroscientists, senior healthcare executives, several major universities, hospital systems and NGOs to join forces with us to create the nation’s first highly personalized and integrated end-to-end model of OUD care.

We are building a care delivery approach, clinical model and enabling technology platform (Treus™) that will meaningfully improve upon and disrupt the current delivery of OUD care.

 

Our experience and track record developing and building our previous healthcare company helps inform our mission and strategy.

 

We are obsessively focused on unmet patient needs and the unmet needs of the stakeholders that serve them.

Do You Know?

Social Determinants of Health Solutions Begin with the Integration of Coordination and Accountability (not referrals or hand offs).

Leadership Team

Person

Raphael Rakowski

Founder, CEO, Strategy

  • Proven healthcare disruptor CEO
  • Medically Home founder – former CEO
  • Former Healthways president
  • Deep experience in decentralized care delivery
“Complex issues demand integrated thinking, passionate innovators, stubbornness for results, child-like curiosity and authentic empathy for the pain, shame and suffering of OUD patients and their families.”
Person

Andy Lipman

Founder, CFO, Business Program Lead

  • Proven business builder, investor
  • Medically Home Founder – former CFO
  • Buy, build, grow strategy and execution
  • Deep experience in decentralized care delivery
  • Founder/Leader of numerous startups and buy/build strategies
“I have had the great fortune of seeing how patients’ lives can be transformed through new models of care. I’m excited about contributing my experience to make a profound impact on people suffering with OUD.”
Person

Paula Calabrese

Founder, Chief Product Officer

  • Strong track record in IP development
  • Deep background in healthcare design, IT
  • Medically Home
  • Tokyo Electron
“At Neurofinity, we are redefining what it means to care for patients with opioid use disorder. By combining scientific rigor and technology solutions with deep compassion, we are committed to delivering personalized solutions that empower patients, support providers, and drive systemic change in the fight against addiction.”
Person

Don Parker

Founder, Clinical Program Lead

  •  42 YRS. BH CEO
  • Hackensack Meridian Health and Carrier Health
  • Deep experience in addiction recovery
  • Malcolm Baldridge Award for Leadership
“Finally, after 50 years tackling OUD as a social worker, I get to be on a path to treating addiction as a disease of the brain, worthy of the same cutting edge scientific treatment as cancer or heart disease. We are combining insatiable curiosity with deep experience and boundless energy to catalyze treatment advances by bridging the world of science with recovery.”

Neurofinity’s Medical and Scientific Advisory Board

Steve
Strongwater, MD
Primary Care/VBC
Atrius Health, Geisinger
Michael
Apkon, MD
Health System Integration
Behavioral Health
Tufts Medical Center,
Hospital for Sick Children
(Toronto)
Phil
Capp, MD
Payer Strategy Behavioral Health
Providence, Optum
Justin
Yang, MD, MPH
Addiction Medicine
Harvard, Pelago
Sung
Poblete, RN
Philanthropy
Stand Up To Cancer, FARE
Philip
Parks, MD, MPH
Innovation, Tech-Enabled
Health Services
Cardinal Health, Exact
Sciences, U.S. Navy
Joseph
Frassica, MD
Physiologic Measurements,
Medical Informatics, AI
Phillips, MIT
John
Foreyt, PhD
Food Addiction
Behavioral Health
Baylor College of Medicine
Marco
Greenberg
Branding/Marketing
Thunder 11
Jeremy
Abbate
Scientific Thought Leadership
Scientific American
Brian
Kinsella
Behavioral Health 501(c)(3)
Integration Veterans Health Care
Stop Soldier Suicide, Rappore

Do You Know?

On average it takes between six months and two years to “recondition” a brain’s wiring response to stress, anxiety, trauma, isolation, boredom, and cravings.